Introduction {#Sec1}
============

In most bacteria, the cytoplasmic membrane is surrounded by a peptidoglycan layer, which gives the cell its shape and provides resistance to internal turgor pressure^[@CR1]^. The peptidoglycan sacculus also serves as an anchoring device for surface proteins and other cell wall components such as teichoic acids and extracellular polysaccharides^[@CR2]--[@CR5]^. During cell division and growth, the peptidoglycan synthesis machineries add new material into the existing cell wall. In ovoid bacteria, such as the important human pathogen *Streptococcus pneumoniae*, two modes of cell wall synthesis occur. The divisome synthesizes the septal crosswall, while extension of the lateral cell body is carried out by the elongasome^[@CR6],[@CR7]^. The cell wall synthesis machineries of *S*. *pneumoniae* contain six penicillin binding proteins (PBPs), five of which participate in building the cell wall via transglycosylase and transpeptidase reactions. The class A PBPs, PBP1a, PBP2a, PBP1b, perform both reactions, while the class B PBPs, PBP2b and PBP2x, only have transpeptidase activity. Recently, it was discovered that the monofunctional class B enzymes PBP2x and PBP2b operate in conjunction with FtsW and RodA, two newly discovered transglycosylases belonging to the SEDS family proteins ([s]{.ul}hape, [e]{.ul}longation, [d]{.ul}ivision and [s]{.ul}porulation)^[@CR8],[@CR9]^. The sixth PBP, PBP3, is a D,D-carboxypeptidase that reduces the level of inter peptide cross-bridges in the peptidoglycan by cleaving off the C-terminal D-Ala residue in stem pentapeptides^[@CR10]^. PBP2b and RodA have been found to be essential for cell elongation, while PBP2x and FtsW are essential for synthesis of the septal disc. Functional studies and subcellular localizations suggest that PBP2b/RodA and PBP2x/FtsW are key components of the elongasome and the divisome, respectively^[@CR11]--[@CR14]^. It is not clear whether the elongasome- and divisome activities alternate or if these machineries work simultaneously during cell division^[@CR6],[@CR15]^. However, some data suggest a short period of cell elongation before the onset of septal peptidoglycan synthesis^[@CR12],[@CR16]^.

In contrast to rod-shaped bacteria, *S*. *pneumoniae* lacks MreB, a cytoskeleton-like protein that moves with the cell wall synthesis machinery in helical patterns perpendicular to the cell length axis^[@CR17]^. Instead, pneumococci elongate by inserting new peptidoglycan into the existing cell wall between the future cell equator and the septum in a circumferentially motion guided by the FtsZ/FtsA division ring^[@CR6],[@CR18]--[@CR21]^. At some point during cell elongation, the divisome initiates septal cross wall synthesis. If the coordinated activities of the elongasome and the divisome get out of control, it leads to severe growth defects and development of morphological abnormalities^[@CR11],[@CR13],[@CR22]^. The cells have therefore developed sophisticated systems to monitor cell cycle progression in order to fine-tune the activity of the elongasome and divisome during cell division. One of these systems includes the membrane-spanning eukaryotic-like serine/threonine kinase StkP. It has four extracellular cell-wall-binding PASTA domains, which are believed to monitor the status of the cell wall during division and activate the appropriate cell division proteins through phosphorylation^[@CR23]--[@CR26]^.

In a recent study we found that EloR, which is phosphorylated by StkP on threonine 89^[@CR27]^, is a key regulator of cell elongation in *S*. *pneumoniae*^[@CR28]^. Our results indicated that EloR stimulates cell elongation when phosphorylated, while being inactive or preventing elongation in its non-phosphorylated form. Moreover, we found that Δ*eloR* cells can survive without PBP2b and its cognate SEDS transglycosylase RodA, demonstrating that deletion of *eloR* supresses the need for a functional elongasome in *S*. *pneumoniae*. Cells lacking EloR displayed a significant reduction in growth rate and became short and round^[@CR28],[@CR29]^. EloR is a cytoplasmic protein of 37 kDa comprising three different domains: an N-terminal jag-domain of unknown function followed by two RNA-binding domains, a type II KH domain (KH-II) and R3H, at the C-terminal end ^[@CR30],[@CR31]^. In a recent study Zheng *et al*.^[@CR32]^ showed that EloR co-precipitates with a protein called KhpA after treating cells with formaldehyde cross linker. KhpA is a small (8.9 kDa) RNA-binding protein that consists only of a type II KH domain. Similar to EloR, deletion of the *khpA* gene supresses the need for a fully functional elongasome, as *pbp2b* as well as *rodA* can be deleted in a Δ*khpA* mutant^[@CR32]^. EloR and KhpA must bind specific target RNAs probably resulting in modulated expression of cell division proteins during different stages of the cell cycle. In support of this hypothesis Zheng *et al*.^[@CR32]^ reported that the absence of EloR or KhpA results in higher cellular levels of the cell division protein FtsA, and that this increase compensates for the loss of PBP2b^[@CR32]^. Homologs of EloR and KhpA appear to be widespread in many Gram-positive bacteria, and are found in genera such as *Streptococcus*, *Bacillus*, *Clostridium*, *Listeria*, *Enterococcus*, *Lactobacillus* and *Lactococcus*. The conservation of these proteins across large phylogenetic distances indicates that they are central players in the cell elongation and division machineries of low G + C Gram-positive bacteria.

In the present study, we show that KhpA homodimerizes, and that it in addition interacts with the KH-II domain of EloR forming an EloR/KhpA heterodimer. Furthermore, we identified amino acids critical for these interactions. We successfully constructed a single amino acid mutant of KhpA that fails to homodimerize but still interacts with EloR, and a single amino acid mutant that neither self-interacts nor heterodimerizes. The unique properties of these KhpA versions were used to demonstrate that the function of EloR is compromised when it is no longer able to interact with KhpA, resulting in cells phenocopying Δ*eloR* and Δ*khpA* mutants (reduced cell elongation). Finally, *in vivo* localization studies showed that KhpA co-localizes with FtsZ throughout the cell cycle, and that this localization pattern depends on its interaction with EloR.

Results {#Sec2}
=======

KhpA interacts with itself and the KH-II-domain of EloR {#Sec3}
-------------------------------------------------------

In a recent study we showed that the loss of EloR suppresses the need of a functional elongasome in *S*. *pneumoniae* since *pbp2b* and *rodA* could be deleted^[@CR28]^. Soon after this, Zheng and co-workers published that EloR co-precipitated with a small protein (8.9 kDa) called KhpA in formaldehyde crosslinking experiments. In addition, they found that a Δ*khpA* mutant phenocopies a Δ*eloR* mutant and that both proteins bound to a similar set of RNA molecules in pulldown experiments^[@CR32]^. In the present work, we utilized a bacterial two-hybrid system (BACTH assay) to further study the interaction between EloR and KhpA. The BACTH system is based on interaction-mediated reconstitution of the *Bordetella pertussis* adenylate cyclase CyaA, which consists of two domains (T18 or T25). When brought together through interaction of the proteins tested, the active T18-T25 reconstitution produces cAMP, which ultimately results in measurable β-galactosidase production in the *E*. *coli* host^[@CR33]^. When testing full-length EloR against KhpA in the BACTH assay, we observed a clear positive interaction (Fig. [1](#Fig1){ref-type="fig"}), confirming the crosslinking results of Zheng and co-workers^[@CR32]^. Next, we wanted to identify the part of EloR that interacts with KhpA. To do so, each of the three domains of EloR (Jag, KH-II and R3H) was tested individually against KhpA (Fig. [1](#Fig1){ref-type="fig"}). The results clearly showed that KhpA specifically interacts with the KH-II-domain of EloR (KH-II^EloR^).Figure 1BACTH-assay showing that KhpA interacts directly with EloR and with itself. KhpA (orange shape) was probed against full-length EloR, the R3H domain, the KH-II^EloR^ domain, the Jag domain and EloR missing the C-terminal R3H domain (EloR^ΔR3H^) (blue shapes). Positive interactions (blue spots) were only seen between KhpA and parts of EloR having the KH-II^EloR^ domain. The positive self-interaction of KhpA is shown at the bottom.

Since KH-domains recognize on average up to four nucleotides, they have a tendency to interact with each other to bind longer sequences and thereby increase their target specificity^[@CR31],[@CR34]^. We therefore suspected that KhpA self-interacts and forms homodimers. BACTH assays using KhpA fused to T18 and T25 resulted in a positive signal (Fig. [1](#Fig1){ref-type="fig"}), suggesting that KhpA, in addition to interacting with EloR, also forms homodimers.

Identification of amino acid residues crucial for KhpA homo- and EloR/KhpA heterodimerization {#Sec4}
---------------------------------------------------------------------------------------------

We reasoned that a 3D model of KhpA might help us identify amino acids that are crucial for homodimerization and heterodimerization with EloR. KH-domains have a highly conserved fold and many 3D-structures are available in the databases^[@CR31],[@CR34]^. To predict the 3D structure of KhpA, we used the online structure prediction tool iTasser. As expected, the predicted structure shows a typical KH-II domain (C-score = −0.36) consisting of three α-helices packed against a three-stranded β-sheet (α-β-β-α-α-β) (Fig. [2A](#Fig2){ref-type="fig"}). The conserved RNA binding cleft is made up of the third α-helix and the third β-strand. The typical GxxG loop that interacts with the phosphate backbone of the ssRNA (or in some cases ssDNA) is located between the α2- and α3-helices (marked in green in Fig. [2A](#Fig2){ref-type="fig"}). Introduction of two aspartates in this loop (GDDG) abolishes binding of target RNA^[@CR35]^. To predict the interaction surface between two KhpA molecules, we did protein docking using ZDOCK with the 3D-model of KhpA as input. According to the model (ZDOCK score = 895.421), the α3-helix creates an anti-parallel interaction surface between two KhpA proteins, resulting in a homodimeric structure where the GxxG loops of the two proteins point in opposite directions (Fig. [2B](#Fig2){ref-type="fig"}). Based on this structure, we made four different mutant versions of KhpA in which single amino acids predicted to protrude from the α3-helix was altered (R53K, R59K, T60Q and I61F). The point mutated versions of KhpA were then tested for their ability to homodimerize by performing BACTH assays. The changes in position 53, 59 or 60 did not dramatically reduce homodimerization, but changing I61 to the bulkier phenylalanine abolished the interaction between KhpA monomers (Fig. [2C](#Fig2){ref-type="fig"}). In our 3D model, a bulky phenylalanine in position 61 cannot fit in a dimeric structure due to steric hindrance (Fig. [2B](#Fig2){ref-type="fig"}), complying with the loss of homodimerization. The model also shows that R53 locates on opposite sides in a KhpA dimer, while R59 sticks into the RNA binding cavity (see supplemental Fig. [S1](#MOESM1){ref-type="media"}), which might explain why changing these residues did not give any dramatic effect on dimerization. The T60, on the other hand, appears to be in close contact in a KhpA dimer (Fig. [S1](#MOESM1){ref-type="media"}), but it seems to be less important for dimerization than I61.Figure 2Structure prediction of KhpA using iTasser and ZDOCK. (**A**) KhpA was predicted to have the typical α-β-β-α-α-β fold of KH-II domains, with the I61 (shown in magenta) protruding from the α3-helix. (**B**) (upper) Protein-protein docking of KhpA homodimers using ZDOCK. The α3-helix of two KhpA molecules are predicted to make contact anti-parallel of each other forming a homodimer where the GXXG RNA-binding loops (shown in green) point in opposite directions. The I61 (magenta) of two KhpA monomers are brought in close proximity in the dimeric structure, facilitating a hydrophobic contact surface. (lower) The dimeric model of the I61F substitution suggests that the phenyl ring does not fit properly into the space between the two KhpA molecules probably because this space is occupied by Tyr63 (yellow) and Ser64 (cyan) of the other KhpA molecule. (**C**) BACTH assay showing KhpA's ability to form homodimers when selected amino acids in the α3-helix were changed (R53K, R59K, T60Q and I61F). Positive interactions appear as blue spots.

To get more accurate data on the effect of the I61F mutation, we chose to measure the β-galactosidase production when performing BACTH (see Materials and Methods). Indeed, the KhpA^I61F^ mutant protein has completely lost the ability to self-interact, but can still form heterodimers with EloR (Fig. [3A](#Fig3){ref-type="fig"}). In an attempt to create a KhpA mutant that does not form homodimers nor EloR/KhpA heterodimers, I61 was changed to tyrosine, which adds a polar hydroxyl group to the bulky phenyl ring. When tested in BACTH assays, our results showed that the KhpA^I61Y^ mutant has lost the ability to interact with itself and the interaction with EloR was dramatically reduced (Fig. [3A](#Fig3){ref-type="fig"}).Figure 3The α3-helix of KhpA is critical for self-dimerization and for EloR/KhpA complex formation. (**A**) Measurements of β-galactosidase production in BACTH assays testing the interaction between EloR and KhpA, KhpA^I61F^ or KhpA^I61Y^ in addition to EloR^L239Y^ against KhpA (green bars). β-galactosidase production resulting from homodimerization of KhpA, KhpA^I61F^ and KhpA^I61Y^ is represented by orange bars, while negative and positive controls are shown in grey. (**B**) Immunoblot detection of 3xflag-EloR in strain RH425, SPH448, AW334 and AW336. A Crosslinked EloR/KhpA complex was observed in strain AW336 under non-reducing conditions, but not after reduction with β-mercaptoethanol (+BME). The image is cropped from the full-length immunoblot, which is shown in Fig. S3.

Amino acid sequence alignment of the KH-II^EloR^ domain and KhpA, suggests that leucine 239 (L239) in EloR corresponds to I61 in KhpA (see supplemental Fig. [S2](#MOESM1){ref-type="media"}). Accordingly, when L239 in EloR was substituted with a tyrosine, KhpA could no longer interact with EloR^L239Y^, showing that this residue is indeed important for EloR/KhpA heterodimerization (Fig. [3A](#Fig3){ref-type="fig"}). To prove that L239 and I61 are in close proximity in the EloR/KhpA heterodimer, we replaced these two amino acids with cysteins to determine whether this would result in a disulfide bridge between the two proteins *in vivo*. A pneumococcal strain expressing the mutant proteins EloR^L239C^ and KhpA^I61C^ was therefore constructed (strain AW336). EloR^L239C^ contained an N-terminal 3xflag-tag to allow detection with α-flag antibodies. Strain AW336 was grown to exponential phase, harvested, and lysed using SDS loading buffer with or without the reducing agent β-mercaptoethanol (see Material and Methods). Next, samples were analyzed by SDS-PAGE followed by immunoblotting. In non-reduced cell lysates, we detected a shift in band size corresponding to the complex between EloR and KhpA (Fig. [3B](#Fig3){ref-type="fig"}). This shift was not present in samples where β-mercaptoethanol had been added to break the disulfide bond, or in any of the samples containing wild type 3xflag-EloR or 3xflag-EloR^L239C^ only. This confirms the interaction between KhpA and the KH-II domain of EloR *in vivo*, and that I61 in the α3-helix of KhpA interacts directly with L239 in the α3-helix of the KH-II^EloR^ domain.

Prevention of EloR/KhpA heterodimerization relieves the requirement of *pbp2b* {#Sec5}
------------------------------------------------------------------------------

A Δ*khpA* mutant phenocopies a Δ*eloR* mutant^[@CR32]^. Both mutants have reduced growth rates, form shorter cells and are viable without a functional elongasome (i.e. without a *pbp2b* or *rodA* gene)^[@CR28],[@CR32]^. We hypothesized that the reason why Δ*khpA* cells phenocopies Δ*eloR* cells is because deletion of either will prevent the formation of the EloR/KhpA complex. In other words, the elongasome only becomes essential when the EloR/KhpA complex is able to form and carry out its normal biological function. To test this hypothesis we exploited the unique properties of KhpA^I61F^ and KhpA^I61Y^. KhpA^I61F^ does not form homodimers, but form heterodimers with EloR, while KhpA^I61Y^ is unable to form either. First, we examined if expression of KhpA^I61F^ or KhpA^I61Y^ generated cells with reduced growth rate similar to a Δ*khpA* mutant. Deletion of *khpA* (strain DS420) increased the doubling time with approximately 15 minutes, which complies with previous findings (15--30 minutes)^[@CR32]^, while strains expressing KhpA^I61F^ or KhpA^I61Y^ (AW212 and AW275) had growth rates similar to the wild type strain (data not shown). Microscopic examination of KhpA^I61F^ or KhpA^I61Y^ cells showed that the KhpA^I61Y^ strain grew in short chains similar to KhpA deficient cells. The KhpA^I61F^ strain on the other hand grew mainly as diplococci similar to the wild type strain (Fig. [4A](#Fig4){ref-type="fig"}). By measuring cell lengths and widths, it became evident that KhpA^I61Y^ cells, in which KhpA is unable to form a complex with EloR, have a rounder cell morphology with reduced cell elongation similar to Δ*khpA* cells (Fig. [4B](#Fig4){ref-type="fig"}). This phenotype is also characteristic for Δ*eloR* cells^[@CR28],[@CR29],[@CR32]^. In contrast, cells expressing the monomeric version of KhpA (I61F) that can still form a complex with EloR, displayed a normal length/width distribution (Fig. [4B](#Fig4){ref-type="fig"}).Figure 4(**A**) Comparison of the morphology of strain RH425 (wt), DS420 (Δ*khpA*), AW212 (I61F) and AW275 (I61Y). Loss of KhpA homodimerization (KhpA^I61F^) produced cells with morphology similar to wild type. Cells in which KhpA no longer interacts with EloR (KhpA^I61Y^) had morphologies resembling the Δ*khpA* mutant. The microscopy images are representatives of whole cell populations. Scale bars are 2 µm. (**B**) Comparison of the cell-shape distribution (length/width) of Δ*khpA*-, KhpA^I61F^- and KhpA^I61Y^-cells (in green) with wild type cells (in grey). KhpA^I61Y^ and Δ*khpA* cells were both significantly different from wild type (p \< 0.05, two-sample t-test), while the shape distribution of KhpA^I61F^ cells was similar to wild type. C. Quantitative BACTH assay showing that KhpA^GDDG^ self-dimerizes and forms complex with EloR.

To further test our hypothesis that EloR/KhpA heterodimerization is required for normal elongasome function, we compared pneumococcal mutants expressing KhpA^I61F^, KhpA^I61Y^ and EloR^L239Y^ (AW279) with respect to the essentiality of their *pbp2b* gene. Indeed, *pbp2b* could be deleted in KhpA^I61Y^ and EloR^L239Y^ cells with normal transformation frequencies, but not in KhpA^I61F^ cells (see Table [S1](#MOESM1){ref-type="media"}). Deletion of *pbp2b* in these strains could not be attributed to decreased stability of the mutated EloR and KhpA version since immunodetection of Flag-tagged EloR^L239Y^, KhpA^I61F^ and KhpA^I61Y^ showed that they were expressed at similar levels as the wild type proteins (see Fig. [S4](#MOESM1){ref-type="media"}). Since it has been shown that mutants expressing a KhpA are unable to bind ssRNA (changing the ssRNA-binding motif GxxG to GDDG) have a Δ*khpA/ΔeloR* phenotype^[@CR32]^, we wondered whether this was because KhpA^GDDG^ had reduced interaction with EloR. However, our BACTH assay showed that KhpA^GDDG^ successfully formed a complex with EloR (Fig. [4C](#Fig4){ref-type="fig"}), and we confirmed that *pbp2b* could be deleted in pneumococci expressing KhpA^GDDG^, as also reported by Zheng *et al*.^[@CR32]^. This demonstrates that PBP2b becomes redundant in cells having an EloR/KhpA complex in which KhpA no longer binds RNA or when KhpA no longer interacts with EloR.

EloR recruits KhpA to the division site {#Sec6}
---------------------------------------

KhpA and EloR have been shown to co-localize to the septal region of dividing cells^[@CR28],[@CR32]^. Since they form heterodimers *in vivo*, we wondered if KhpA is recruited to mid-cell through its interaction with EloR. To explore this, the subcellular localization of sfGFP-fused KhpA (KhpA-sfGFP was functional since *pbp2b* could not be deleted in strain AW5, see Table [S1](#MOESM1){ref-type="media"}) was determined in wild type cells and in a Δ*eloR* mutant (Fig. [5](#Fig5){ref-type="fig"}). A subtle mid-cell enrichment of KhpA-sfGFP was found in 73.2% of wild type cells, confirming previous findings^[@CR32]^. In contrast, KhpA-sfGFP was found at mid-cell in only 0.5% of the Δ*eloR* mutant cells. To show that it is the direct interaction between KhpA and EloR that localizes KhpA to the division site and not some indirect effect of deleting the *eloR* gene, we fused sfGFP to KhpA^I61F^ and KhpA^I61Y^. As expected, KhpA^I61Y^-sfGFP, which does not bind EloR, lost its localization to mid-cell (found at mid-cell in only 2% of the cells). The monomeric KhpA^I61F^-sfGFP are still able to interact with EloR and displayed significantly higher degree of mid-cell enrichment (found at mid-cell in 19% of the cells). In accordance with these results, expression of EloR^L239Y^, which cannot interact with KhpA, resulted in mislocalization of KhpA-sfGFP (Fig. [5](#Fig5){ref-type="fig"}). Together, these results show that KhpA is recruited to mid-cell through complex formation with EloR.Figure 5Micrographs showing the localization of KhpA-sfGFP in strain AW5 (wt), AW238 (Δ*eloR*), AW267 (KhpA^I61F^-sfGFP), AW321 (KhpA^I61Y^-sfGFP) and AW353 (EloR^L239Y^). The percent of cells having KhpA-sfGFP enriched to mid-cell are indicated. Scale bars are 2 µm.

To determine whether the EloR/KhpA complex is recruited to the division zone during early, late or all stages of cell division, we compared the localization patterns of KhpA and FtsZ. FtsZ forms the division ring, which functions as a scaffold for a number of proteins found in the elongasome and divisome. FtsZ is therefore present at the division zone during initiation of new septa, cell elongation and cross wall synthesis, but it is not required for the final stage of daughter cell separation^[@CR12],[@CR18]^. KhpA-sfGFP and FtsZ fused to the fluorescent marker mKate2 were co-expressed in *S*. *pneumoniae* (strain AW198), and fluorescence microscopy images demonstrate that KhpA-sfGFP enriched at mid-cell follows the same localization pattern as FtsZ (Fig. [6](#Fig6){ref-type="fig"}). This shows that the EloR/KhpA complex is recruited to the division zone at the very early stage, and that it remains co-localized with the cell division machineries throughout the cell cycle. Note, however, that KhpA is not exclusively co-localized with FtsZ as it is also found throughout the cytoplasm.Figure 6Localization of KhpA-sfGFP and mKate2-FtsZ at different stages of cell division. (**A**) Microscopic examination of strain AW198 showed that KhpA-sfGFP co-localizes to the division site with FtsZ-mKate2 during cell division. Scale bars are 2 µm. (**B**) The fluorescence maximum signals of FtsZ-mKate2 and KhpA-sfGFP plotted relative to cell length. 437 cells were analyzed.

Discussion {#Sec7}
==========

It has been shown previously that Δ*khpA* and Δ*eloR* mutant strains are similar in several respects. They both exhibit reduced cell lengths, and are able to survive without PBP2b and other essential components of the elongasome^[@CR28],[@CR32]^. The fact that Δ*khpA* and Δ*eloR* mutants have similar phenotypes could suggest that KhpA and EloR are acting at different steps in the same regulatory pathway. However, the finding that KhpA co-precipitates with EloR after formaldehyde crosslinking^[@CR32]^ suggests an alternative model, namely that they function as a single unit and that disruption of this complex gives rise to the phenotypes described above. The results presented in the present work prove that the latter model is correct. Disruption of the EloR/KhpA complex by introduction of site-specific amino acid substitutions, gives rise to shorter cells and renders the elongasome redundant (Fig. [7](#Fig7){ref-type="fig"}). It is therefore likely that its role is to stimulate or control elongasome-mediated lateral cell wall synthesis. To do this, our results show that KhpA must be able to bind its target nucleic acid, which is most likely ssRNA. The typical binding surface of KH-domains can only accommodate four unpaired bases^[@CR31],[@CR34]^, and consequently has low binding specificity. It is reasonable to assume that the RNA sequence motifs recognized by KhpA and the KH-II domain of EloR are different. Hence, by combining the two domains in a heterodimer the binding specificity and affinity for its target ssRNA(s) are substantially increased. Another possible role for the interaction between EloR and KhpA could be to bridge two segments on an RNA molecule by binding two distant motifs, inducing a loop formation. Such loops are proposed to facilitate binding of posttranscriptional regulatory protein complexes^[@CR34],[@CR36],[@CR37]^. Identification of the EloR/KhpA RNA target(s) will be an important goal for future research seeking to understand the function of the EloR/KhpA system.Figure 7Model depicting EloR- and KhpA dependent cell elongation. KhpA binds the KH-II domain of EloR, which recruits KhpA to the division zone where new cell wall is synthesized. At the division zone the EloR/KhpA complex regulates cell elongation by binding RNA. Whether EloR/KhpA binds one or more specific sequence motifs or specific RNA secondary structures, and how binding of RNA regulates cell division are still not settled. A monomeric KhpA does not render cells independent on PBP2b as long as it still forms a complex with EloR. If the interaction between EloR and KhpA is broken, KhpA loses its mid-cell localization and binding to the target RNA(s) is most probably reduced or lost. Since EloR requires the RNA binding activity of KhpA to function, preventing EloR/KhpA complex formation results in compromised cell elongation.

Our results show that KhpA also forms homodimers, which might have their own distinct biological function (see Figs [1](#Fig1){ref-type="fig"} and [3A](#Fig3){ref-type="fig"}). However, our preliminary studies did not detect any obvious functional deficits or major phenotypic changes associated with the KhpA^I61F^ mutation, i.e. the mutation disrupting the formation of KhpA homodimers without preventing the formation of EloR/KhpA heterodimers. As the docking model shows, the KhpA monomers are likely arranged in an antiparallel orientation in the dimer so that they will be able bind two successive sequence motifs on the same RNA strand. The binding of two motifs will increase the target sequence specificity considerably, and will make the RNA sequence motif recognized by the homodimer different from that recognized by the EloR/KhpA heterodimer. Considering this, and that the KhpA^I61F^ and KhpA^I61Y^ mutations give rise to completely different phenotypes, it is likely that the KhpA homodimers and EloR/KhpA heterodimers serve different biological functions.

The EloR/KhpA heterodimer contains three RNA-binding domains, i.e two domains from EloR (KH-II and R3H) and one from KhpA. The presence of several RNA-binding domains is a common feature of proteins containing KH-domains. As mentioned above, this increases target specificity and is also believed to have an important role in the folding of ssRNA sequences^[@CR34]^. Based on the present and previous studies^[@CR28],[@CR29],[@CR32]^, we know that the EloR/KhpA complex requires the combined action of all three RNA-binding domains to regulate cell elongation. However, it is not known whether all three domains bind to the same RNA strand, or if the KH-II^EloR^/KhpA complex binds one strand while the R3H domain binds another. The crystal structure of an EloR homolog from *Clostridium symbosium* (PDB 3GKU) suggests a dimeric structure^[@CR38]^, which in principle could bind two KhpA molecules resulting in a complex with a total of six RNA-binding domains. To test this possibility we used the BACTH system to determine if EloR from *S*. *pneumoniae* forms homodimers. The results were inconclusive as we obtained just a weak positive signal (data not shown). Hence, we cannot conclude whether the biologically active complex between EloR and KhpA is dimeric (EloR/KhpA) or tetrameric (KhpA/EloR/EloR/KhpA).

Synthesis of the lateral cell wall takes place in an area close to the division septum, possibly where the division septum meets the periphery of the cell. Previous studies show that EloR and KhpA localize to the septal region^[@CR28],[@CR32]^. Here, we show that KhpA homodimers are found throughout the cytoplasm (strain AW353) (Fig. [5](#Fig5){ref-type="fig"}), while KhpA/EloR heterodimers localize together with FtsZ to the division site (AW198) (Fig. [6](#Fig6){ref-type="fig"}). This finding support the notion that these homo- and heterodimers serve different functions. Of note, FtsZ has been reported to disappear from the septum prior to both essential cell division proteins PBP2x (divisome) and PBP2b (elongasome)^[@CR12]^. Since KhpA co-localizes with the FtsZ-ring throughout the cell cycle, it suggests that a functional EloR/KhpA complex is important during the stages of cell division, which involves active peptidoglycan synthesis during cell elongation and early to mid crosswall synthesis, but not during the final stage of cell division.

Zheng and co-workers report that the levels of FtsA, which together with FtsZ assembles into the division ring^[@CR6],[@CR18],[@CR39],[@CR40]^, were elevated two- to threefold in Δ*eloR* and Δ*khpA* mutants. Their results suggest that EloR and KhpA bind 5′ untranslated regions of mRNAs, including the *ftsA* transcript, resulting in altered translation rates^[@CR32]^. In support of this hypothesis they found that *pbp2b* could be deleted in wild type D39 cells overexpressing FtsA, although overexpression of FtsA could not fully restore the wild type phenotype of Δ*eloR*/Δ*khpA* cells^[@CR32]^. We attempted to reproduce the described effect of elevated FtsA levels in our D39 strain. However, despite using the exact same expression conditions, i.e. overexpression of *ftsA* and its 24 nt upstream region from a P~Zn~ zinc-inducible promoter, we were not successful. Nevertheless, translational control of specific mRNAs seems to be the most probable mode of action for the EloR/KhpA complex.

Interestingly, the *eloR* gene is co-transcribed with a gene called *yidC* in *S*. *pneumoniae*^[@CR41]^ and most likely in several other bacteria including *S*. *thermophilus*, *L*. *monocytogenes*, *B*. *subtilis*, *L*. *lactis*, *E*. *faecium* and *L*. *plantarum*. Such conserved co-transcription could indicate a functional relationship between the genes. YidC is an insertase that assists in co-translational insertion of membrane proteins into the lipid bilayer. It functions together with the SecYEG translocon, the signal recognition particle (SRP) and the SRP-receptor FtsY. During co-translational protein targeting to the SecYEG translocon, the SRP-ribosome-nascent protein chain complex is first targeted to FtsY, which delivers the chain to the SecYEG translocon channel. The function of YidC is to facilitate the release of the transmembrane domains of inner membrane proteins from the channel into the lipid bilayer^[@CR42],[@CR43]^. Having this in mind, it is tempting to speculate that the EloR/KhpA complex could be involved in regulating the expression and insertion of specific membrane proteins involved in cell elongation through translational control.

Methods {#Sec8}
=======

Bacterial strains, cultivation and transformation {#Sec9}
-------------------------------------------------

All strains used in this work are listed in Table [1](#Tab1){ref-type="table"}. *E*. *coli* strains were grown in LB broth at 37 °C with shaking (200 rpm), or on LB plates at 37 °C unless otherwise indicated. When necessary the following antibiotics were used: kanamycin (50 µg/ml) and ampicillin (100 µg/ml). Transformation experiments were performed with chemically competent cells using the heat shock method at 42 °C for 45 seconds. *S*. *pneumoniae* were grown in C medium^[@CR44]^ or on Todd Hewitt-agar plates at 37 °C. Agar plates were incubated in anaerobic chambers using AnaeroGen^TM^ bags from Oxoid. When necessary, kanamycin (400 µg/ml) and streptomycin (200 µg/ml) were employed for selection of transformants. In order to knock out genes or introduce mutations, natural genetic transformation was employed. For transformation experiments, the culture was grown to an OD~550~ of 0.05--0.1 and mixed with the transforming DNA (100--200 ng) and CSP1, which was added to a final concentration of 250 ng/ml. After 2 hours of incubation at 37 °C, 30 µl of the culture was plated on TH-agar containing the appropriate antibiotic followed by incubation at 37 °C over night. To investigate growth rates of different mutants, cultures were grown to an OD~550~ of 0.2, diluted to OD~550~ = 0.05, and grown in 96-well Corning NBS clear-bottom plates in a Synergy H1 Hybrid Reader (BioTek). The OD~550~ was measured automatically every 5 minutes for 20 hours.Table 1*S*. *pneumoniae* strains used in the present study.NameRelevant characteristicsReferenceR704R6 derivative, *comA::ermAM*; Ery^R^JP. Claverys\*RH425R704, but streptomycin resistant; Ery^R^, Sm^R[@CR54]^DS420Δ*comA*, Δ*khpA*; Ery^R^, Sm^R^This workDS428Δ*comA*, Δ*khpA*, Δ*pbp2b::janus*; Ery^R^, Kan^R^This workDS764Δ*comA*, *flag-khpA*^*I61F*^; Ery^R^, Sm^R^This workDS765Δ*comA*, *flag-khpA*^*I61Y*^; Ery^R^, Sm^R^This workDS766Δ*comA*, *flag-eloR*^*L239Y*^; Ery^R^, Sm^R^This workAW5Δ*comA*, *khpA-sfgfp*; Ery^R^, Sm^R^This workAW9Δ*comA*, *flag-khpA*; Ery^R^, Sm^R^This workAW24Δ*comA*, *khpA*^*GDDG*^; Ery^R^, Sm^R^This workAW27Δ*comA*, *khpA*^*GDDG*^, Δ*pbp2b::janus*; Ery^R^, Kan^R^This workAW198Δ*comA*, *khpA-sfgfp*, *ftsZ-mKate2-Km*; Ery^R^, Km^R^, Sm^R^This workAW212Δ*comA*, *khpA*^*I61F*^; Ery^R^, Sm^R^This workAW238Δ*comA*, *khpA-sfgfp*, Δ*eloR*; Ery^R^, Sm^R^This workAW267Δ*comA*, *khpA*^*I61F*^*-sfgfp*; Ery^R^, Sm^R^This workAW275Δ*comA*, *khpA*^*I61Y*^; Ery^R^, Sm^R^This workAW279Δ*comA*, *eloR*^*L239Y*^; Ery^R^, Sm^R^This workAW313Δ*comA*, *khpA*^*I61Y*^, Δ*pbp2b::janus*; Ery^R^, Kan^R^This workAW314Δ*comA*, *eloR*^*L239Y*^, Δ*pbp2b::janus*; Ery^R^, Kan^R^This workAW321Δ*comA*, *khpA*^*I61Y*^*-sfgfp*; Ery^R^, Sm^R^This workAW334Δ*comA*, *flag-eloR*^*L239C*^; Ery^R^, Sm^R^This workAW336Δ*comA*, *flag-eloR*^*L239C*^, *khpA*^*I61C*^; Ery^R^, Sm^R^This workAW353Δ*comA*, *khpA-sfgfp*, *eloR*^*L239Y*^; Ery^R^, Sm^R^This workSPH445Δ*comA*, Δ*eloR*, Ery^R^, Sm^R[@CR28]^SPH446Δ*comA*, Δ*eloR*, Δ*pbp2b::janus*; Ery^R^, Kan^R[@CR28]^SPH448Δ*comA*, *flag-eloR*; Ery^R^, Sm^R[@CR28]^RR66D39 derivative, *ftsZ-mKate2*, Kan^R[@CR47]\*^Gift from Professor Jean-Pierre Claverys, CNRS, Toulouse, France.

Construction of genetic mutants, gene fusions and point mutations {#Sec10}
-----------------------------------------------------------------

DNA amplicons used in transformation experiments were created with overlap extension PCR as previously described^[@CR45]^. Genes were knocked out using a Janus cassette^[@CR46]^. The cassettes were created with sequences of \~1000 bp homologous to the flanking sequences of the insertion site in the genome. The same technique was employed when introducing point mutations or fusion genes. Primers used to create these amplicons are listed in Table [S2](#MOESM1){ref-type="media"}. The ftsZ-mKate2 fusion gene together with a kanamycin resistance cassette was amplified from genomic DNA of strain RR66^[@CR47]^. All constructs were verified with PCR and Sanger Sequencing.

SDS-PAGE and immunoblotting {#Sec11}
---------------------------

The strains RH425, SPH448, AW334 and AW336 were grown to an OD~550~ of 0.3 in a culture volume of 45 ml. The cells were harvested at 4000 × *g*, and resuspended in 200 µl 1 × SDS sample buffer not containing any reducing agents. The samples were then split in two, and β-mercaptoethanol was added to one parallel half of the samples to a final concentration of 100 mM. All the samples (including the non-reduced) were heated at 100 °C for 10 minutes. The cell lysates were separated on a 15% polyacrylamide gel with buffer conditions as previously described^[@CR48]^. For immunodetection purposes, the separated proteins were electroblotted onto a PVDF membrane (BioRad), and flag-EloR was detected with α-flag antibodies as previously described^[@CR49]^. To detect the expression of Flag-EloR, Flag-EloR^L239Y^, Flag-KhpA, Flag-KhpA^I61F^ and Flag-KhpA^I61Y^, strain SPH448, DS766, AW9, DS764 and DS765 were grown to OD~550~ = 0.3 in 10 ml C medium. Flag-tagged proteins were then detected in whole cell lysates as described above.

BACTH-assay {#Sec12}
-----------

The bacterial adenylate cyclase two hybrid (BACTH) assay, is based on the functional complementation of T18 and T25, two domains of the *B*. *pertussis* adenylate cyclase (CyaA)^[@CR33]^. When these domains are brought in close proximity to each other, they can actively produce cAMP. The production of cAMP leads to activation of the catabolite activator protein CAP, which in a complex with cAMP activates expression of a reporter gene placed behind the cAMP/CAP promoter. The reporter gene used in this system encodes the β-galactosidase enzyme. In order to investigate the interaction between two proteins, we cloned genes encoding the proteins of interest in frame with either the T25 -or the T18-encoding sequences in plasmids provided by the manufacturer (Euromedex). The plasmids used in this study are listed in Table [S3](#MOESM1){ref-type="media"}. Next, two plasmids, each expressing one protein fused to either T18 or T25 were transformed into *E*. *coli* BTH101 cells (a *cya*^−^ strain). After overnight incubation on LB plates containing kanamycin (50 µg/ml) and ampicillin (100 µg/ml), five colonies from each transformation were grown in LB containing the appropriate antibiotics. When reaching an OD~600~ of 0.2, three µl of the cell cultures were spotted onto LB plates containing 0.5 mM IPTG (to induce expression of the fusion genes), X-gal (40 µg/ml), kanamycin (50 µg/ml) and ampicillin (100 µg/ml). After an overnight incubation at 30 °C, results were interpreted as positive or negative based on the color of the spot. A positive interaction between the proteins of interest will result in blue spots on a plate. In addition, the production of β-galactosidase reporter was measured by performing β-galactosidase assays using ortho-nitrophenyl-β-galactoside (ONPG) as substrate. *E*. *coli* BTH101 containing plasmids with T18 and T25-fused genes were grown in the presence of kanamycin (50 µg/ml) and ampicillin (100 µg/ml) to OD~600~ = 0.4--0.5. Then the cells were diluted to OD~600~ = 0.05 in similar medium also containing 0.5 mM IPTG. The cells were incubated at 30 °C with shaking for 4 hours. Cells from one ml culture were lysed using 0.5 g of ≤106 µm glass beads (Sigma) and bead beating at 6.5 m/s for 3 × 20 seconds. Then the β-galactosidase activity in 100 µl cell lysate was determined following the protocol of Steinmoen *et al*.^[@CR50]^.

Microscopy and cell shape distribution analyses {#Sec13}
-----------------------------------------------

The subcellular localization of different point mutated versions of the KhpA proteins was examined by fluorescence microscopy. The mutated proteins in question were fused to sfGFP^[@CR47]^ via a short glycine-linker (GGGGG). sfGFP fusions were expressed in the native *khpA* locus in the *S*. *pneumoniae* genome (strains AW5, AW198, AW238, AW267, AW321 and AW353).

The cell morphology and cell shape distributions were examined by phase contrast microscopy. Microscopy experiments were performed by growing the strains to an OD~550~ of 0.1 before immobilizing the cells on a microscopy slide using 1.2% low melting agarose (Biorad) in PBS. Phase contrast images and GFP fluorescence images were obtained using a Zeiss AxioObserver with ZEN Blue software, and an ORCA-Flash 4.0 V2 Digital CMOS camera (Hamamatsu Photonics) using a 1003 phase-contrast objective. The ImageJ plugin MicrobeJ^[@CR51]^ was used to analyze the cell shape and the subcellular localization of KhpA-sfGFP and FtsZ-mKate2. Cells were segmented using the phase contrast images. Cell shape distributions were made by calculating length/width for the individual cell and the significance of the differences between distributions were determined using a two-sample t-test. To determine the percentage of cells having KhpA-sfGFP enriched at mid-cell, the GFP fluorescence profiles were plotted for the individual cells. KhpA-sfGFP was scored as mid-cell localized when a fluorescence maximum peak was found in the mid-cell area (between 40--60% of the cell length), and the percentage of cells with KhpA-sfGFP enriched at mid-cell was calculated. To analyze the subcellular localization of FtsZ-mKate2 and KhpA-sfGFP, the Maxima-option in MicrobeJ was used.

3D-modelling {#Sec14}
------------

The online structure determination tool iTasser was used to predict the 3D-structure of KhpA. It uses algorithms to predict protein 3D structure based on the amino acid sequence and known, published structures^[@CR52]^. KhpA was modeled based on the solved structure of the KH-II domain of PDB entry 3gku (21% sequence identity and 60% similarity with KhpA). The ZDOCK server was used to predict the interaction surface in a KhpA homodimer^[@CR53]^. Based on the predicted interaction surface in a KhpA homodimer, we created point mutated versions of KhpA, introduced these into the BACTH system, and tested interactions between mutated KhpA proteins and between mutated KhpA and wild type EloR.
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